Urinary concentrations of PAH and VOC metabolites in marijuana users

Environment International

Volumn 88, Issue , 2016, Pages 1-8

  Wei, Binnian ^a   Alwis, K Udeni ^a   Li, Zheng ^a   Wang, Lanqing ^a   Valentin Blasini, Liza ^a   Sosnoff, Connie S ^a   Xia, Yang ^a   Conway, Kevin P ^b   Blount, Benjamin C ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Biomonitoring; Cannabis smoke; Environmental tobacco smoke (ETS); PAHs; Secondhand smoke; VOCs

Indexed keywords

AMIDES; BIOMOLECULES; HEALTH RISKS; POLYCYCLIC AROMATIC HYDROCARBONS; PUBLIC HEALTH; REGRESSION ANALYSIS; SMOKE; SURVEYS; TOBACCO; VOLATILE ORGANIC COMPOUNDS;

BIOMONITORING; COMBUSTION BY-PRODUCTS; ENVIRONMENTAL TOBACCO SMOKES; MULTIPLE REGRESSION ANALYSIS; POLYCYCLIC AROMATIC HYDROCARBONS (PAHS); POTENTIAL HEALTH RISKS; SECONDHAND SMOKES; URINARY METABOLITES;

METABOLITES;

1 HYDROXYNAPHTHALENE; 1 HYDROXYPHENANTHRENE; 1 HYDROXYPYRENE; 2 HYDROXYFLUORENE; 2 HYDROXYPHENANTHRENE; 2 METHYLHIPPURIC ACID; 2 NAPHTHOL; 2 THIOXOTHIAZOLIDINE 4 CARBOXYLIC ACID; 3 HYDROXYFLUORENE; 3 HYDROXYPHENANTHRENE; 3 METHYLHIPPURIC ACID; 9 HYDROXYFLUORENE; MANDELIC ACID; N ACETYL (2 CARBAMOYL 2 HYDROXYETHYL)LEVO CYSTEINE; N ACETYL (2 CARBAMOYLETHYL)LEVO CYSTEINE; N ACETYL (2 CARBOXYETHYL)LEVO CYSTEINE; N ACETYL (2 CYANOETHYL)LEVO CYSTEINE; N ACETYL (2 HYDROXYPROPYL)LEVO CYSTEINE; N ACETYL (3 HYDROXYPROPYL 1 METHYL)LEVO CYSTEINE; N ACETYL (3 HYDROXYPROPYL)LEVO CYSTEINE; N ACETYL (3,4 DIHYDROXYBUTYL)LEVO CYSTEINE; N ACETYL (4 HYDROXY 2 BUTEN 1 YL)LEVO CYSTEINE; N ACETYL (BENZYL)LEVO CYSTEINE; N ACETYL (N METHYLCARBAMOYL)LEVO CYSTEINE; N ACETYL (PHENYL)LEVO CYSTEINE; PHENYLGLYOXYLIC ACID; POLYCYCLIC AROMATIC HYDROCARBON; TRANS, TRANS MUCONIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VOLATILE ORGANIC COMPOUND; BIOLOGICAL MARKER; CANNABIS; PASSIVE SMOKING;

BIOMONITORING; CONCENTRATION (COMPOSITION); DRUG USER; HEALTH RISK; METABOLITE; PAH; QUESTIONNAIRE SURVEY; URINE; VOLATILE ORGANIC COMPOUND;

ADULT; ARTICLE; CANNABIS USE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GEOMETRY; HUMAN; LIMIT OF DETECTION; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SELF REPORT; URINALYSIS; ADOLESCENT; ADVERSE EFFECTS; CANNABIS SMOKING; CASE CONTROL STUDY; MIDDLE AGED; PASSIVE SMOKING; URINE; YOUNG ADULT;

CANNABIS; CANNABIS SATIVA; NICOTIANA TABACUM;

ADOLESCENT; ADULT; BIOMARKERS; CANNABIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; MIDDLE AGED; POLYCYCLIC AROMATIC HYDROCARBONS; TOBACCO SMOKE POLLUTION; VOLATILE ORGANIC COMPOUNDS; YOUNG ADULT;

EID: 84949661468     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2015.12.003     Document Type: Article

References (54)

1. Aldington S., Harwood M., Cox B., Weatherall M., Beckert L., Hansell A., Pritchard A., Robinson G., Beasley R. Cannabis use and risk of lung cancer: a case-control study. Eur. Respir. J. 2008, 31(2):280-286.
2. Alwis K.U., Blount B.C., Britt A.S., Patel D., Ashley D.L. Simultaneous analysis of 28 urinary voc metabolites using ultra high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (UPLC-ESI/MSMS). Anal. Chim. Acta 2012, 750:152-160.
3. Barr D.B., Wilder L.C., Caudill S.P., Gonzalez A.J., Needham L.L., Pirkle J.L. Urinary creatinine concentrations in the US population: implications for urinary biologic monitoring measurements. Environ. Health Perspect. 2005, 113(2):192.
4. Bernert J.T., McGuffey J.E., Morrison M.A., Pirkle J.L. Comparison of serum and salivary cotinine measurements by a sensitive high-performance liquid chromatography-tandem mass spectrometry method as an indicator of exposure to tobacco smoke among smokers and nonsmokers. J. Anal. Toxicol. 2000, 24(5):333-339.
5. Bernert J.T., Pirkle J.L., Xia Y., Jain R.B., Ashley D.L., Sampson E.J. Urine concentrations of a tobacco-specific nitrosamine carcinogen in the US population from secondhand smoke exposure. Cancer Epidemiol. Biomark. 2010, 19(11):2969-2977.
6. Berthiller J., Straif K., Boniol M., Voirin N., Benhaïm-Luzon V., Ayoub W.B., Dari I., Laouamri S., Hamdi-Cherif M., Bartal M. Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J. Thorac. Oncol. 2008, 3(12):1398-1403.
7. Block R.I., O'Leary D.S., Hichwa R.D., Augustinack J.C., Ponto L.L.B., Ghoneim M.M., Arndt S., Ehrhardt J.C., Hurtig R.R., Watkins G.L. Cerebellar hypoactivity in frequent marijuana users. Neuroreport 2000, 11(4):749-753.
8. Blount B.C., Valentin-Blasini L. Analysis of perchlorate, thiocyanate, nitrate and iodide in human amniotic fluid using ion chromatography and electrospray tandem mass spectrometry. Anal. Chim. Acta 2006, 567(1):87-93.
9. Brown H.L., Graves C.R. Smoking and marijuana use in pregnancy. Clin. Obstet. Gynecol. 2013, 56(1):107-113.
10. Caudill S.P., Schleicher R.L., Pirkle J.L. Multi-rule quality control for the age-related eye disease study. Stat. Med. 2008, 27(20):4094-4106.
11. Chait L., Pierri J. Some physical characteristics of Nida marijuana cigarettes. Addict. Behav. 1989, 14(1):61-67.
12. Clark A., Ware M., Yazer E., Murray T., Lynch M. Patterns of cannabis use among patients with multiple sclerosis. Neurology 2004, 62(11):2098-2100.
13. English D., Hulse G., Milne E., Holman C., Bower C. Maternal cannabis use and birth weight: a meta-analysis. Addiction 1997, 92(11):1553-1560.
14. Fehr K.O.B., Kalant H. Analysis of cannabis smoke obtained under different combustion conditions. Can. J. Physiol. Pharmacol. 1972, 50(8):761-767.
15. Fergusson D.M., Horwood L.J., Northstone K. Maternal use of cannabis and pregnancy outcome. BJOG 2002, 109(1):21-27.
16. Gray T.R., Eiden R.D., Leonard K.E., Connors G.J., Shisler S., Huestis M.A. Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clin. Chem. 2010, 56(9):1442-1450.
17. Hall W., Degenhardt L. Medical marijuana initiatives. CNS Drugs 2003, 17(10):689-697.
18. Hall W., Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009, 374(9698):1383-1391.
19. Hecht S.S., Carmella S.G., Stepanov I., Jensen J., Anderson A., Hatsukami D.K. Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total nnal in smokeless tobacco users. Cancer Epidemiol. Biomark. 2008, 17(3):732-735.
20. Horton A., Guerin M. Quantitative determination of sulfur compounds in the gas phase of cigarette smoke. J. Chromatogr. A 1974, 90(1):63-70.
21. Huestis M.A. Cannabis(marijuana) - effects on human behavior and performance. Forensic Sci. Rev. 2002, 14(1):15-60.
22. Huizink A. Prenatal cannabis exposure and infant outcomes: overview of studies. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2014, 52:45-52.
23. Jamal A., Agaku I.T., O'Connor E., King B.A., Kenemer J.B., Neff L. Current cigarette smoking among adults - United States, 2005-2013. MMWR 2014, 63(47):1108-1112. (Available from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6347a4.htm [accessed on June 30, 2015]).
24. Jones R.T. Cardiovascular system effects of marijuana. J. Clin. Pharmacol. 2002, 42(S1):58S-63S.
25. Lee M., Novotny M., Bartle K. Gas chromatography/mass spectrometric and nuclear magnetic resonance spectrometric studies of carcinogenic polynuclear aromatic hydrocarbons in tobacco and marijuana smoke condensates. Anal. Chem. 1976, 48(2):405-416.
26. Li Z., Romanoff L.C., Trinidad D.A., Hussain N., Jones R.S., Porter E.N., Patterson D.G., Sjödin A. Measurement of urinary monohydroxy polycyclic aromatic hydrocarbons using automated liquid-liquid extraction and gas chromatography/isotope dilution high-resolution mass spectrometry. Anal. Chem. 2006, 78(16):5744-5751.
27. Li Z., Romanoff L.C., Trinidad D.A., Pittman E.N., Hilton D., Hubbard K., Carmichael H., Parker J., Calafat A.M., Sjödin A. Quantification of 21 metabolites of methylnaphthalenes and polycyclic aromatic hydrocarbons in human urine. Anal. Bioanal. Chem. 2014, 406:3119-3129.
28. Li Z., Sandau C.D., Romanoff L.C., Caudill S.P., Sjodin A., Needham L.L., Patterson D.G. Concentration and profile of 22 urinary polycyclic aromatic hydrocarbon metabolites in the US population. Environ. Res. 2008, 107(3):320-331.
29. Lovreglio P., Barbieri A., Carrieri M., Sabatini L., Fracasso M.E., Doria D., Drago I., Basso A., D'Errico M.N., Bartolucci G.B. Validity of new biomarkers of internal dose for use in the biological monitoring of occupational and environmental exposure to low concentrations of benzene and toluene. Int. Arch. Occup. Environ. Health 2010, 83(3):341-356.
30. Maertens R.M., White P.A., Rickert W., Levasseur G., Douglas G.R., Bellier P.V., McNamee J.P., Thuppal V., Walker M., Desjardins S. The genotoxicity of mainstream and sidestream marijuana and tobacco smoke condensates. Chem. Res. Toxicol. 2009, 22(8):1406-1414.
31. Mark K., Desai A., Terplan M. Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes. Arch. Womens Ment. Health 2015, 1-7.
32. Mittleman M.A., Lewis R.A., Maclure M., Sherwood J.B., Muller J.E. Triggering myocardial infarction by marijuana. Circulation 2001, 103(23):2805-2809.
33. Moir D., Rickert W.S., Levasseur G., Larose Y., Maertens R., White P., Desjardins S. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem. Res. Toxicol. 2008, 21(2):494-502.
34. Murray R.M., Morrison P.D., Henquet C., Di Forti M. Cannabis, the mind and society: the hash realities. Nat. Rev. Neurosci. 2007, 8(11):885-895.
35. Pankow J.F., Luo W., Tavakoli A.D., Chen C., Isabelle L.M. Delivery levels and behavior of 1,3-butadiene, acrylonitrile, benzene, and other toxic volatile organic compounds in mainstream tobacco smoke from two brands of commercial cigarettes. Chem. Res. Toxicol. 2004, 17(6):805-813.
36. Pirkle J.L., Bernert J.T., Caudill S.A., Sosnoff C.S., Pechacek T.F. Trends in the exposure of nonsmokers in the US population to secondhand smoke: 1988-2002. Environ. Health Perspect. 2006, 114(6):853-858.
37. Pirkle J.L., Flegal K.M., Bernert J.T., Brody D.J., Etzel R.A., Maurer K.R. Exposure of the US population to environmental tobacco smoke - the third national health and nutrition examination survey, 1988 to 1991. JAMA J. Am. Med. Assoc. 1996, 275(16):1233-1240.
38. Rickert W.S., Robinson J., Rogers B. A comparison of tar, carbon monoxide and ph levels in smoke from marihuana and tobacco cigarettes. Can. J. Public Health 1982, 73(6):386.
39. SAMHSA Results from the 2013 national survey on drug use and health: summary of national findings Available from, (Accessed on: June 16, 2015). http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf.
40. Schauer G.L., King B.A., Bunnell R.E., Promoff G., McAfee T.A. Toking, vaping, and eating for health or fun: Marijuana use patterns in adults, US, 2014. Am. J. Prev. Med. 2015.
41. Solowij N., Stephens R.S., Roffman R.A., Babor T., Kadden R., Miller M., Christiansen K., McRee B., Vendetti J. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002, 287(9):1123-1131.
42. Taylor D.R., Fergusson D.M., Milne B.J., Horwood L.J., Moffitt T.E., Sears M.R., Poulton R. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 2002, 97(8):1055-1061.
43. Tetrault J.M., Crothers K., Moore B.A., Mehra R., Concato J., Fiellin D.A. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch. Intern. Med. 2007, 167(3):221-228.
44. UNODC United Nations Office on Drugs and Crime. World Drug Report 2014, (Available from http://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf [accessed on June 14, 2015]).
45. US-CDC Survey design factors-sample design, weighting and variance estimation Available from, (Accesed on November 12, 2015). http://www.cdc.gov/nchs/tutorials/NHANES/SurveyDesign/intro.htm.
46. US-CDC Biological specimens collection Available from, (Accessed on November 12, 2014). http://www.cdc.gov/nchs/nhanes/nhanes2011-2012/labdoc_g.htm.
47. US-CDC The National Health and Nutrition Examination Survey (NHANES) analytic and reporting guidelines Available from, (Accessed on July 24th, 2015). http://www.cdc.gov/nchs/nhanes/survey_methods.htm.
48. Valentín-Blasini L., Blount B.C., Delinsky A. Quantification of iodide and sodium-iodide symporter inhibitors in human urine using ion chromatography tandem mass spectrometry. J. Chromatogr. A 2007, 1155(1):40-46.
49. Ware M., Adams H., Guy G. The medicinal use of cannabis in the UK: results of a nationwide survey. Int. J. Clin. Pract. 2005, 59(3):291-295.
50. Wei B., Bernert J.T., Blount B.C., Sosnoff C.S., Wang L., Richter P., Pirkle J.L. Temporal Trends of Secondhand Smoke Exposure: Nonsmoking Workers in the United States (NHANES 2001-2010) 2015, (under review).
51. Wei B., Blount B.C., Xia B., Wang L. Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012. J. Expo. Sci. Environ. Epidemiol. 2015, 10.1038/jes.2014.88.
52. Wei B., Feng J., Rehmani I.J., Miller S., McGuffey J.E., Blount B.C., Wang L. A high-throughput robotic sample preparation system and HPLC-MS/MS for measuring urinary anatabine, anabasine, nicotine and major nicotine metabolites. Clin. Chim. Acta 2014, 436:290-297.
53. Wei B., Wang L., Blount B.C. Analysis of cannabinoids and their metabolites in human urine. Anal. Chem. 2015, 87(20):10183-10187.
54. Xia Y., McGuffey J.E., Bhattacharyya S., Sellergren B., Yilmaz E., Wang L., Bernert J.T. Analysis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine by extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Anal. Chem. 2005, 77(23):7639-7645.